Related Experiment Video
Updated: Jun 5, 2026
15:43
Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
Published on: March 17, 2014
[Pseudomonas aeruginosa in chronic obstructive pulmonary disease]
Aurélia Wavre-Oberhänsli1, Laurent P Nicod
1Service de pneumologie, CHUV, 1011 Lausanne. aurelia.wavre@chuv.ch
Revue Medicale Suisse
|January 7, 2011
Summary
Pseudomonas aeruginosa in chronic obstructive pulmonary disease (COPD) can increase exacerbation risk. Its role beyond exacerbations and the benefit of prophylactic antibiotics in COPD patients remain unclear.
Area of Science:
- Pulmonary Medicine
- Infectious Diseases
- Microbiology
Background:
- The role of Pseudomonas aeruginosa in chronic obstructive pulmonary disease (COPD) is not well understood.
- This bacterium possesses numerous virulence factors contributing to various clinical manifestations in COPD patients.
Purpose of the Study:
- To investigate the significance of Pseudomonas aeruginosa in adults with obstructive COPD.
- To explore the pathogen's role in disease exacerbations and progression.
Main Methods:
- Sputum cultures were analyzed from adult patients diagnosed with obstructive COPD.
- Prevalence and association of Pseudomonas aeruginosa isolation with COPD severity and exacerbations were assessed.
Main Results:
- Isolation of new Pseudomonas strains correlates with a significant risk of COPD exacerbation.
- The prevalence of Pseudomonas aeruginosa is dependent on the severity of COPD.
- The pathogen's role in airway inflammation and disease progression in COPD is suggested but not fully elucidated.
Conclusions:
- Pseudomonas aeruginosa poses a risk for COPD exacerbations, with prevalence linked to disease severity.
- Further research is needed to clarify its role in non-exacerbation phases and its impact on disease progression.
- The efficacy of prophylactic antibiotic therapy in COPD patients colonized with Pseudomonas aeruginosa has not been established.
More Related Videos
Related Concept Videos
01:29Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
01:30Pneumonia I: Introduction
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...